Shonan Kamakura General Hospital

Kamakura, Kanagawa 247-8533

3 studies enrolling now · 12 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Alzheimer Disease (AD), Alzheimer´s Disease, Aortic Valve Stenosis, Atrial Fibrillation, Bleeding, CAD, COVID-19 SARS-CoV-2 Infection, Chronic Kidney Disease, Non-Small Cell Lung Cancer (NSCLC), Relapsed or Refractory Multiple Myeloma, Stroke

Studies at this site

• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) — Recruiting now
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Cryo Global Registry — Completed
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed
• Coronary Orbital Atherectomy System Study — Completed
• Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. — Completed
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease — Stopped early